Drugs for obesity, Alzheimer’s, and infectious diseases herald a new era of innovation in the pharma business
BY ALICE PARK
t’s been a while since the pharmaceutical industry last saw a year like 2023, when the U.S. Food and Drug Administration (FDA) approved a slew of groundbreaking and life-changing medications that represent a surge in innovation—and a potential boon to
